Award
National Institute of Allergy and Infectious Diseases PA-24-182
A Transposon-based Gene Drive to Combat Antimicrobial Resistance
Recipient
BRIGHAM AND WOMEN'S HOSPITAL
Award Amount
$171,046.00
Ceiling
$171,046.00
Awarded
April 01, 2026
Identifier
PA-24-182
Award for research to develop a gene drive system targeting antimicrobial resistance in E. coli ST131, conducted at Brigham and Women's Hospital, Boston, funded by NIAID.
Description
This project aims to develop a transposon-based gene drive to combat antimicrobial resistance, focusing on E. coli ST131 as a model pathogen. The project involves developing a gene drive system that can eliminate resistance genes from bacterial populations, with potential applications in medical and ecological settings. The award supports research activities at Brigham and Women's Hospital in Boston, MA, under the auspices of NIAID. The project duration is from April 1, 2026, to March 31, 2031.